These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3679674)

  • 1. Chemical synthesis of phosphoseryl-phosphoserine, a partial analogue of human salivary statherin, a protein inhibitor of calcium phosphate precipitation in human saliva.
    Schlesinger DH; Buku A; Wyssbrod HR; Hay DI
    Int J Pept Protein Res; 1987 Aug; 30(2):257-62. PubMed ID: 3679674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete primary structure of statherin, a potent inhibitor of calcium phosphate precipitation, from the saliva of the monkey, Macaca arctoides.
    Schlesinger DH; Hay DI; Levine MJ
    Int J Pept Protein Res; 1989 Nov; 34(5):374-80. PubMed ID: 2613439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of calcium phosphate precipitation by human salivary acidic proline-rich proteins: structure-activity relationships.
    Hay DI; Carlson ER; Schluckebier SK; Moreno EC; Schlesinger DH
    Calcif Tissue Int; 1987 Mar; 40(3):126-32. PubMed ID: 3105842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete covalent structure of a proline-rich phosphoprotein, PRP-2, an inhibitor of calcium phosphate crystal growth from human parotid saliva.
    Schlesinger DH; Hay DI
    Int J Pept Protein Res; 1986 Apr; 27(4):373-9. PubMed ID: 3710693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between concentration of human salivary statherin and inhibition of calcium phosphate precipitation in stimulated human parotid saliva.
    Hay DI; Smith DJ; Schluckebier SK; Moreno EC
    J Dent Res; 1984 Jun; 63(6):857-63. PubMed ID: 6429216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete covalent structure of statherin, a tyrosine-rich acidic peptide which inhibits calcium phosphate precipitation from human parotid saliva.
    Schlesinger DH; Hay DI
    J Biol Chem; 1977 Mar; 252(5):1689-95. PubMed ID: 838735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships.
    Schwartz SS; Hay DI; Schluckebier SK
    Calcif Tissue Int; 1992 Jun; 50(6):511-7. PubMed ID: 1525706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis and characterization of human salivary statherin: a tyrosine-rich phosphoprotein inhibitor of calcium phosphate precipitation.
    Gururaja TL; Levine MJ
    Pept Res; 1996; 9(6):283-9. PubMed ID: 9048421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoproteins in the parotid saliva from the subhuman primate Macaca fascicularis. Isolation and characterization of a proline-rich phosphoglycoprotein and the complete covalent structure of a proline-rich phosphopeptide.
    Oppenheim FG; Offner GD; Troxler RF
    J Biol Chem; 1982 Aug; 257(16):9271-82. PubMed ID: 7107568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human salivary proteins on the precipitation kinetics of calcium phosphate.
    Moreno EC; Varughese K; Hay DI
    Calcif Tissue Int; 1979 Aug; 28(1):7-16. PubMed ID: 115554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of salivary proline-rich protein and peptide synthesis: cell-free translations and processing of human and macaque statherin mRNAs and partial amino acid sequence of their signal peptides.
    Oppenheim FG; Hay DI; Smith DJ; Offner GD; Troxler RF
    J Dent Res; 1987 Feb; 66(2):462-6. PubMed ID: 3476566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturation of human salivary secretions with respect to calcite and inhibition of calcium carbonate precipitation by salivary constituents.
    Hay DI; Schluckebier SK; Moreno EC
    Calcif Tissue Int; 1986 Sep; 39(3):151-60. PubMed ID: 3093026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of inhibitory activity on calcium phosphate precipitation by acidic proline-rich proteins, statherin, and histatin-1.
    Tamaki N; Tada T; Morita M; Watanabe T
    Calcif Tissue Int; 2002 Jul; 71(1):59-62. PubMed ID: 12060866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption behavior of statherin and a statherin peptide onto hydroxyapatite and silica surfaces by in situ ellipsometry.
    Santos O; Kosoric J; Hector MP; Anderson P; Lindh L
    J Colloid Interface Sci; 2008 Feb; 318(2):175-82. PubMed ID: 18054952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of human salivary statherin from Escherichia coli using two different fusion constructs.
    Gilbert M; Stayton PS
    Protein Expr Purif; 1999 Jul; 16(2):243-50. PubMed ID: 10419821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a rabbit salivary protein, a potent inhibitor of crystal growth of calcium phosphate salts.
    Spielman AI; Bernstein A; Hay DI; Blum M; Bennick A
    Arch Oral Biol; 1991; 36(1):55-63. PubMed ID: 2012527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric identification of key proteolytic cleavage sites in statherin affecting mineral homeostasis and bacterial binding domains.
    Helmerhorst EJ; Traboulsi G; Salih E; Oppenheim FG
    J Proteome Res; 2010 Oct; 9(10):5413-21. PubMed ID: 20731414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva and dental caries.
    Dowd FJ
    Dent Clin North Am; 1999 Oct; 43(4):579-97. PubMed ID: 10553245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural features of salivary function.
    Lamkin MS; Oppenheim FG
    Crit Rev Oral Biol Med; 1993; 4(3-4):251-9. PubMed ID: 8373982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcium-carbonate precipitation by human salivary proline-rich phosphoproteins.
    Saitoh E; Isemura S; Sanada K
    Arch Oral Biol; 1985; 30(8):641-3. PubMed ID: 3863562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.